BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35253204)

  • 21. Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study.
    Andersson TM; Eriksson H; Hansson J; Månsson-Brahme E; Dickman PW; Eloranta S; Lambe M; Lambert PC
    Cancer Epidemiol; 2014 Feb; 38(1):93-9. PubMed ID: 24447700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival and prognostic factors in patients with localised cutaneous melanoma observed between 1980 and 1991 at the Istituto Dermopatico dell'Immacolata in Rome, Italy.
    Corona R; Sciò M; Mele A; Ferranti G; Mostaccioli S; Macchini V; Sonego G; Ferrigno L; Fucci M; Osborn JF
    Eur J Cancer; 1994; 30A(3):333-8. PubMed ID: 8204355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical correlates of Breslow thickness of malignant melanoma.
    Osborne JE; Hutchinson PE
    Br J Dermatol; 2001 Mar; 144(3):476-83. PubMed ID: 11260002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conditional recurrence-free survival in patients with primary stage I-II cutaneous malignant melanoma - a population-based study.
    Lyth J
    Melanoma Res; 2018 Dec; 28(6):637-640. PubMed ID: 29994850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced disease-specific survival following a diagnosis of multiple primary cutaneous malignant melanomas-a nationwide, population-based study.
    Utjés D; Lyth J; Lapins J; Eriksson H
    Int J Cancer; 2017 Dec; 141(11):2243-2252. PubMed ID: 28799271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival in 31 670 patients with thin melanomas: a Swedish population-based study.
    Isaksson K; Mikiver R; Eriksson H; Lapins J; Nielsen K; Ingvar C; Lyth J
    Br J Dermatol; 2021 Jan; 184(1):60-67. PubMed ID: 32133615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
    Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
    Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma.
    Barnhill RL; Katzen J; Spatz A; Fine J; Berwick M
    J Cutan Pathol; 2005 Apr; 32(4):268-73. PubMed ID: 15769275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
    Hoersch B; Leiter U; Garbe C
    Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous malignant melanoma in Swedish children and teenagers 1973-1992: a clinico-pathological study of 130 cases.
    Sander B; Karlsson P; Rosdahl I; Westermark P; Boeryd B
    Int J Cancer; 1999 Mar; 80(5):646-51. PubMed ID: 10048960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness.
    Crocetti E; Carli P
    Eur J Dermatol; 2003; 13(1):72-5. PubMed ID: 12609787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men.
    Lyth J; Eriksson H; Hansson J; Ingvar C; Jansson M; Lapins J; Månsson-Brahme E; Naredi P; Stierner U; Ullenhag G; Carstensen J; Lindholm C
    Br J Dermatol; 2015 Mar; 172(3):700-6. PubMed ID: 25323770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of tumour thickness in cutaneous malignant melanoma.
    Jeffrey I; Royston P; Sowter C; Slavin G; Price A; Pomerance A; Goolamali S; Pinto D
    J Clin Pathol; 1983 Jan; 36(1):51-6. PubMed ID: 6822677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanoma in older patients: declining gap in survival between younger and older patients with melanoma.
    Schuurman MS; Hollestein LM; Bastiaannet E; Posthuma EFM; van Akkooi AJC; Kukutsch NA; Aarts MJB; Wakkee M; Lemmens VEPP; Louwman MWJ
    Acta Oncol; 2020 Jan; 59(1):4-12. PubMed ID: 31347929
    [No Abstract]   [Full Text] [Related]  

  • 36. Time trends in tumour thickness vary in subgroups: analysis of 6475 patients by age, tumour site and melanoma subtype.
    Baumert J; Schmidt M; Giehl KA; Volkenandt M; Plewig G; Wendtner C; Schmid-Wendtner MH
    Melanoma Res; 2009 Feb; 19(1):24-30. PubMed ID: 19430403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study.
    Eriksson H; Frohm-Nilsson M; Järås J; Kanter-Lewensohn L; Kjellman P; Månsson-Brahme E; Vassilaki I; Hansson J
    Br J Dermatol; 2015 Jan; 172(1):175-86. PubMed ID: 24910143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).
    Di Carlo V; Stiller CA; Eisemann N; Bordoni A; Matz M; Curado MP; Daubisse-Marliac L; Valkov M; Bulliard JL; Morrison D; Johnson C; Girardi F; Marcos-Gragera R; Šekerija M; Larønningen S; Sirri E; Coleman MP; Allemani C;
    Br J Dermatol; 2022 Sep; 187(3):364-380. PubMed ID: 35347700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histologic subtype.
    Brunssen A; Jansen L; Eisemann N; Waldmann A; Weberpals J; Kraywinkel K; Eberle A; Holleczek B; Zeissig SR; Brenner H; Katalinic A;
    J Am Acad Dermatol; 2019 Apr; 80(4):938-946. PubMed ID: 30244061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with a high tumour thickness in patients with melanoma.
    Baumert J; Plewig G; Volkenandt M; Schmid-Wendtner MH
    Br J Dermatol; 2007 May; 156(5):938-44. PubMed ID: 17381454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.